INTRODUCTION
On 2nd March, 1981, in a small holding in Thalheim, Lower Austria, symptoms of foot-and-mouth disease (FMD) were discovered in two out of five swine, after an epidemic-free period of six years. The samples were tested on the same day by the complement fixation test (CFT) and the cause of the disease was verified as being FMD virus type O (0-81/1 Original). Subse quently the village of the outbreak was quarantined and a safety area 30 km in radius was established around it. All susceptible animals in the village were slaughtered and destroyed. Three days later all swine from the age of two weeks and all cattle, goats and sheep from the age of two months within the 30 km radius were prophylactically vaccinated.
On 6th March, 1981 , in the community of Pönning, approximately 1 km from the original outbreak, a new case was reported. Only one out of 37 cattle was taken ill. The disease was confirmed on the same day by CFT and FMD virus type O (0-81/2) was diagnosed. Following the diagnosis all cloven-hoofed animals were slaughtered and destroyed.
Approximately ten days after the first outbreak in Thalheim ring vaccina tion was completed. Altogether 80,000 cattle (half of them with monovalent vaccine « I » and half with trivalent vaccine A-O-C « II ») were vaccinated. For the majority of swine, the swine vaccine « III » was used and for a smal ler number the swine vaccine « IV ».
These rigorous measures proved to be effective and further outbreaks have not been recorded.
A plausible explanation for the outbreak could not be established. Suppo sitions that buffalo meat falsely declared as game had caused the epidemic could not be proved.
Some striking deviations in the behaviour of the isolated virus strain and the suggestion of the IFFA Institute, after provisional, unilateral serological comparative tests, that the newly isolated virus differs from O-Lausanne, gave rise to intensive examination of the virus with particular reference to the effectiveness of the vaccines used against it.
MATERIAL AND METHODS
The material taken on the infected farm (0-81/1 Orig.) was used for the infection of swine and cattle. Each sample was tested using the CFT, baby mice and tissue cultures.
The cytopathogenicity of different adaptations of the isolate was exami ned in baby mice and various cell cultures mainly derived from cattle and swine grown in stationary test tubes.
The development of antibodies in vaccinated test animals was ascertained by microplate serum neutralisation tests in IB-RS-2 and SNH cells. In spora dic cases a tube test was also used. The SNH cells are secondary swine kidney cells developed in our Institute. The test used was carried out partly with the varying virus-constant serum method, partly with the constant virus-varying serum method.
The relationship of the new isolate 0-81 with some other O virus strains used for vaccine production was tested with guinea pig hyperimmune sera by cross-neutralisation test in IB-RS-2 cells, mouse neutralisation test and CFT. For the neutralisation test in tissue culture the 5 virus strains were adapted in 5 to 8 monolayer passages to IB-RS-2 and BHK 21 cells. For mouse neutrali sation test and CFT cattle epithelium from the tongue was used.
RESULTS

ANIMAL TESTS a) Pigs infection.
For virus multiplication two pigs were infected intravenously with the ori ginal material from Thalheim :
-Result of the infection : generalisation after three days. The immunity status was examined both under field and laboratory con ditions. The animals were vaccinated with different vaccines (I, II, III, IV and V) or revaccinated with the same vaccines. Three weeks after the last vac cination, the animals were challenged with the originally isolated virus (O-81/1) or with cattle adapted virus (0-81/B3).
The results of the immunity tests can be seen in Tables I-VI, the suscepti  bility of different cells in Table VII. Tables VIII, IX O-Gr. Schweinb.
DISCUSSION
The preceding tables give the results of the immunity tests on cattle and swine. They show unequivocally that the virus strain newly isolated in Aus tria has a strikingly high virulence in swine and in baby mice, in contrast to its low pathogenicity in cattle.
Experimental infection in cattle was delayed, even when using a high virus quantity and led only to insignificant pathomorphological alterations.
As shown in Table V , intradermolingual infection with 10,000 I.D. 0-81/B3 caused a specific local lesion only in one of the cattle which were vaccinated with a conventional A-O-C vaccine, and the unvaccinated control remained uninfected. 13 days later the cattle which were vaccinated and pri marily tested with 0-81/B3, were reinfected with 10,000 I.D. of the strain O-BFS 1860. The result was a generalised disease of both the unvaccinated con trol and two vaccinated cattle. One of the vaccinated cattle developed a local lesion. The cattle which had formerly a local lesion after infection with O-81/B3, proved to be immune against the infection with O-BFS 1860.
Repeated examinations of different passages of the isolate 0-81/1 on various cell cultures produced an unusual result for the FMD virus : The nor mally highly sensitive thyroid and the embryonic bovine kidney cells proved to be unreceptive to the isolate 0-81. The permanent bovine cell line MDBK and the primary cell culture of pig testicles were not susceptible for all tested virus samples. In the used permanent IB-RS-2 cells and also in primary cell cultures of pig kidneys the isolate 0-81 could be multiplied. After adaptation in IB-RS-2 cells we could cultivate the isolate also in BHK-21 cells. Following some passages in monolayers we reached remarkable virus titers in suspen sion culture. Consequently we could perform further fundamental tests with this isolate. Therefore we think that the production of vaccine is possible in BHK-21 suspension culture also with the isolate 0-81. High virus titers were obtained in baby mice which proved to be very susceptible to the isolate O-81.
Intravenous infection and contact infection of swine led without excep tion to generalised disease. Challenge infection in the laboratory by contact of swine which had been vaccinated with various swine vaccines resulted with only one exception in a complete failure of the initial vaccination. Markedly better results were gained by revaccination.
A comparative antibody test against the strains 0-81 and O-BFS 1860 in animals vaccinated with conventional vaccines proved that antibodies against both virus strains existed in both vaccinated cattle and swine. However the serum neutralisation titers for the strain O-BFS 1860 lay slightly higher than those for the 0-81 strain.
The relationships between the strains O-BFS 1860, 0-81/1 and 0-81/2 were tested by the cross-neutralisation test with guinea pig hyperimmune serum. As shown in Tables VIII, IX and X, the strains O-BFS 1860 and OSwizzera are closely related. Strain 0-81 deviates from the virus strains O-BFS 1860 and O-Swizzera. As seen in the use of the cross-neutralisation test the deviation is however not very marked.
In conclusion, our findings suggest that the FMD virus strain recently isolated in Austria does not differ markedly from the known strains of FMD virus O, in its antigenic characteristics but that it is a strain which is naturally adapted to swine, showing only low pathogenicity for cattle. Un segundo caso, aproximadamente a un kilómetro del primero, ocurrió cuatro días después.
RÉSULTATS ACTUELS DE L'ÉTUDE IMMUNOLOGIQUE DU VIRUS O APPARU EN
Acto seguido a la comprobación de la existencia de una epidemia mataron a todos los animales correspondientes en ambos lugares epidémicos, eliminándo-los para evitar el contagio. Alrededor de los lugares epidémicos se inició una acción de vacunación, sometiendo todo ganado bovino, ovino, caprino y porcino dentro de un radio de 30 kilómetros a una vacunación profiláctica.
Las medidas rigurosas contra la epidemia surtieron pleno efecto, ya que no se registraron más casos.
Las claras diferencias en el comportamiento de la cepa del virus aislado eran el motivo de que se sometió lo aislado a un examen serológico e inmunológico más intensivo.
Los estudios dieron por resultado que la cepa del virus, por primera vez aislada en Austria, si bien se distingue serológicamente de las cepas vacunales BFS
